BIOMAT Database Logo BIOMAT Database Logo

Studies on pyrazine derivatives. XXXIII. Synthesis and tuberculostatic activity of 1-[1-(2-pyrazinyl)-ethyl]-4-N-substituted thiosemicarbazide derivatives. 1999

B Milczarska, and H Foks, and J Sokołowska, and M Janowiec, and Z Zwolska, and Z Andrzejczyk
Department of Organic Chemistry, Medical University of Gdańsk, Poland.

Hydrogenation of 4-N-substituted thiosemicarbazonic acid acetylpyrazine derivatives with NaBH4 in dry ethanol led to seventeen new compounds. The in vitro tuberculostatic activity investigations of the 15 synthesized compound were carried out. MIC few of i.v. compounds were lower than 32 micrograms/cm3.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D009170 Nontuberculous Mycobacteria So-called atypical species of the genus MYCOBACTERIUM that do not cause tuberculosis. They are also called tuberculoid bacilli, i.e.: M. abscessus, M. buruli, M. chelonae, M. duvalii, M. flavescens, M. fortuitum, M. gilvum, M. gordonae, M. intracellulare (see MYCOBACTERIUM AVIUM COMPLEX;), M. kansasii, M. marinum, M. obuense, M. scrofulaceum, M. szulgai, M. terrae, M. ulcerans, M. xenopi. Atypical Mycobacteria,Mycobacteria, Atypical,Mycobacterium duvalii,Mycobacterium flavescens,Mycobacterium gilvum,Mycobacterium gordonae,Mycobacterium obuense,Mycobacterium szulgai,Mycobacterium terrae,Mycolicibacter terrae,Mycolicibacterium duvalii,Mycolicibacterium flavescens,Mycolicibacterium gilvum,Mycolicibacterium obuense,Tuberculoid Bacillus,Atypical Mycobacterium,Mycobacterium, Atypical,Non-Tuberculous Mycobacteria,Nontuberculous Mycobacterium
D011719 Pyrazines A heterocyclic aromatic organic compound with the chemical formula C4H4N2. Pyrazine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D013882 Thiosemicarbazones Thiosemicarbazone

Related Publications

B Milczarska, and H Foks, and J Sokołowska, and M Janowiec, and Z Zwolska, and Z Andrzejczyk
[Studies of pyrazine derivatives. XVII. Synthesis and the tuberculostatic activity of pyrazinyl-1,3,4-oxadiazole derivatives].
January 1986, Acta poloniae pharmaceutica,
B Milczarska, and H Foks, and J Sokołowska, and M Janowiec, and Z Zwolska, and Z Andrzejczyk
[Studies on pyrazine derivatives. XXVI. Synthesis and tuberculostatic activity of N-pyrazinylthiourea].
January 1989, Acta poloniae pharmaceutica,
B Milczarska, and H Foks, and J Sokołowska, and M Janowiec, and Z Zwolska, and Z Andrzejczyk
[Studies on pyrazine derivatives. IX. Synthesis and tuberculostatic activity of 2-pyrazinylbenzimidazoles].
January 1978, Acta poloniae pharmaceutica,
B Milczarska, and H Foks, and J Sokołowska, and M Janowiec, and Z Zwolska, and Z Andrzejczyk
Studies on pyrazine derivatives. Part III. The synthesis and tuberculostatic activity of 6-(N-methyl-amino2)-pyrazine-2-carboxylic acid derivatives.
January 1974, Polish journal of pharmacology and pharmacy,
B Milczarska, and H Foks, and J Sokołowska, and M Janowiec, and Z Zwolska, and Z Andrzejczyk
[Studies on pyrazine derivatives. XXII. Synthesis and tuberculostatic activity of the products of reactions of pyrazinyl-1,3,4-oxadiazol-2-thione with amines].
January 1988, Acta poloniae pharmaceutica,
B Milczarska, and H Foks, and J Sokołowska, and M Janowiec, and Z Zwolska, and Z Andrzejczyk
Studies on pyrazine derivatives, XXIX: Synthesis of N1-thioamido substituted pyrazincarboxyamidrazones with expected tuberculostatic activity.
August 1995, Die Pharmazie,
B Milczarska, and H Foks, and J Sokołowska, and M Janowiec, and Z Zwolska, and Z Andrzejczyk
[Studies on pyrazine derivatives. XIX. Synthesis and tuberculostatic activity of various 3-phenoxy-2-pyrazinecarboxylic acid derivatives].
January 1983, Acta poloniae pharmaceutica,
B Milczarska, and H Foks, and J Sokołowska, and M Janowiec, and Z Zwolska, and Z Andrzejczyk
Studies on pyrazine derivatives. Part VII. Synthesis and tuberculostatic activity of some pyrazine amidines and amidoximes.
January 1977, Polish journal of pharmacology and pharmacy,
B Milczarska, and H Foks, and J Sokołowska, and M Janowiec, and Z Zwolska, and Z Andrzejczyk
Studies on pyrazine derivatives. Part V. Synthesis and tuberculostatic activity of some 6-(beta-aminoethoxy)-pyrazine-2-carboxylic acids.
January 1976, Polish journal of pharmacology and pharmacy,
B Milczarska, and H Foks, and J Sokołowska, and M Janowiec, and Z Zwolska, and Z Andrzejczyk
Optimized Synthesis of New Thiosemicarbazide Derivatives with Tuberculostatic Activity.
November 2021, International journal of molecular sciences,
Copied contents to your clipboard!